Omega-3s are far more than a nutritional trend; they are important building blocks for the health and well-being of our canine companions. Recognised for their ability to modulate inflammation and support vital functions, these essential fatty acids play an important role in canine nutrition.
Discover the science behind omega-3s and how to optimise your dog's intake to support joint, cognitive and skin health.
Omega-3s belong to the family of polyunsaturated fatty acids. They are classed as essential because dogs, like humans, cannot produce them in adequate amounts. They must therefore be supplied through food or supplementation.
A fatty acid is a basic component of fats. Omega-3s are called 'polyunsaturated' because of their chemical structure, which makes them particularly flexible and useful in cell membranes.
Within this family, three fatty acids are at the centre of scientific interest:
ALA (Alpha-Linolenic Acid): It is the main precursor, found primarily in plant-based sources such as flaxseed, hemp and walnuts.
EPA (Eicosapentaenoic Acid): Mainly derived from marine organisms such as algae, fish and crustaceans, it plays a key role in regulating inflammation (Bauer, 2007).
DHA (Docosahexaenoic Acid): Also of marine origin, it is important for the development and structure of the nervous system, retina and cell membranes, as well as for cartilage protection (Bauer, 2011).
In dogs, the ability to convert ALA into EPA and DHA is very limited, at less than 10% (National Research Council, 2006). To support biological effectiveness, it is therefore crucial to prioritise direct sources of EPA and DHA.
Mechanism of Action of Omega-3
The benefits of omega-3s stem from their ability to become incorporated into cell membranes, helping the body function effectively at a fundamental level.
Omega-6 / Omega-3 Balance
Commercial dog food often contains considerably more omega-6 than omega-3, partly because of vegetable oils such as corn or sunflower oil. Omega-6 fatty acids are precursors to pro-inflammatory molecules such as series 2 prostaglandins and leukotriene B4.
The Omega-6/Omega-3 Balance: Omega-6 fatty acids are necessary, but an excess can provide the raw materials for inflammatory pathways. An imbalance may therefore promote chronic inflammation (Wander et al., 1997).
When EPA is available in sufficient quantities, it competes with omega-6 fatty acids. It takes their place in cell membranes and in enzymatic reactions (biochemical processes driven by enzymes), leading to the production of mediators that are less harmful to tissues (McPhee et al., 2007; Treschow et al., 2007).
Regulation of Inflammation and Joint Protection
EPA and DHA do not simply slow inflammation; they also help resolve it.
Action on Enzymes: EPA modulates the activity of COX and LOX enzymes, reducing the production of mediators involved in pain and swelling in the joint (Mehler et al., 2016; Adler et al., 2018). Cyclooxygenases and lipoxygenases are enzymes that catalyse the conversion of fats into inflammatory signals. Omega-3s act as a natural 'brake' on these processes.
Resolvins, Protectins and Homeostasis: EPA and DHA are the precursors to a class of 'pro-resolving' molecules: resolvins and protectins. These compounds help bring the inflammatory response to an end and restore tissue balance, a process known as homeostasis (Calder, 2015).
Cellular Protection: DHA, in particular, contributes to stabilising subchondral bone by regulating the activity of osteoclasts (cells responsible for bone resorption), thereby playing an important chondroprotective role in protecting articular cartilage. Osteoclasts break down bone tissue. DHA helps regulate their activity, protecting the bone beneath the cartilage. Its chondroprotective role also helps protect cartilage cells (Rahman et al., 2008; Ma et al., 2023; Wang et al., 2016).
Omega-3s, especially EPA and DHA, are the best-documented active ingredients in canine nutrition for a variety of indications:
Mobility and Joint Comfort
In 2022, researchers from the Faculty of Veterinary Medicine at the University of Montreal published a systematic review of available clinical studies on dietary supplements for arthritic dogs and cats (Barbeau-Grégoire et al., 2022) and concluded that omega-3s were the most effective.
Omega-3 are the most effective and best-documented active ingredients clinically, far ahead of other widely marketed ingredients such as glucosamine, collagen or plant extracts.
Barbeau-Grégoire
Improved mobility: Clinical studies show a reduction in lameness and improved ability to bear weight on the limb (Roush et al., 2010; Moreau et al., 2013).
Pain relief: Reduction in joint stiffness and potentially a decreased need for non-steroidal anti-inflammatory drugs (NSAIDs) (Mehler et al., 2016; Fritsch et al., 2010).
Tissue preservation: Protection of cartilage against chronic enzymatic degradation (Hansen et al., 2008).
Because of their anti-inflammatory properties, omega-3s can provide valuable support for pruritic or atopic dermatitis:
Strengthening of the skin barrier.
Reduction of itching (pruritus) and alopecia caused by self-trauma (Magalhães et al., 2021).
Improvement of coat quality: shinier and denser.
Brain Function and Cognitive Development
DHA is a major constituent of neuronal membranes (the outer structure of nerve cells). Adequate intake is important:
In puppies: It supports neurological development, learning and motor skills (Rodrigues et al., 2023).
In senior dogs: It helps to preserve cognitive function and neuronal plasticity (the brain's ability to form new connections essential to memory and learning) in the face of ageing (Bauer, 2011).
Cardiovascular Support
Omega-3s contribute to cardiovascular regulation by helping to maintain balanced blood pressure and supporting healthy triglyceride levels (Smith et al., 2007; Nasciutti et al., 2021).
The Best Sources of Omega-3
Not all sources of omega-3 are equal, particularly in terms of EPA and DHA purity, traceability and environmental impact.
Plant-based Sources
Flaxseed, rapeseed and hemp oils are rich in ALA, but dogs convert this precursor into EPA and DHA inefficiently. These oils provide beneficial fats, but cannot effectively address an existing omega-3 deficiency.
Classic Marine Sources
Oily Fish (Fish Oils): Traditionally rich in EPA and DHA, oily fish such as sardines, anchovies and mackerel may nevertheless be exposed to contaminants such as heavy metals and PCBs. Their use may also be associated with overfishing and declining omega-3 levels in fish (Lloret et al., 2025; Sprague et al., 2016).
Antarctic Krill: Provides omega-3s in phospholipid form, which is readily absorbed. However, krill is a keystone species in the Antarctic food chain, and large-scale harvesting can put pressure on the marine ecosystem (Meyer et al., 2025; Zhang et al., 2025).
Sustainable Marine Sources
The best sources combine high levels of active omega-3s (EPA and DHA) with impeccable traceability:
Microalgae Oil: Microalgae are a primary source of marine omega-3s. Grown in fermenters, they produce high-purity DHA with no risk of marine heavy-metal contamination and without putting pressure on the oceans. Microalgae oil is a sustainable, highly pure alternative to fish oil.
New Zealand Green-Lipped Mussel Oil(Perna canaliculus): This is a unique source. Its cultivation is strictly regulated and environmentally responsible. It provides not only EPA and DHA, but also rare omega-3s such as ETA (Eicosatetraenoic Acid), known for its specific action on the LOX enzyme and its contribution to the overall anti-inflammatory effect. Its benefits for mobility have been demonstrated in clinical studies involving dogs.
The dose of omega-3s, expressed as total EPA + DHA, is a key factor in effectiveness. It should be adjusted to the intended purpose and may be determined with veterinary guidance if necessary.
At present, French and European authorities have not established recommended omega-3 dosages for dogs. However, guidance can be drawn from doses shown to be effective in the scientific literature:
Omega-3 Dosage
Condition
Effective EPA + DHA Dose
Minimum Duration
Observed Clinical Effects
Severe Joint Disorders
60-100 mg/kg/jour
6 à 12 weeks
Reduced pain and stiffness, improved mobility
Allergic Dermatitis
50-90 mg/kg/jour
8 à 10 weeks
Reduced itching, erythema, and secondary skin lesions
Dull Coat / Poor Coat Condition
EPA : 16 mg/kg DHA : 10 mg/kg
3 months
Improved seborrheic index and coat quality
Joint Health Maintenance & Prevention
14 mg/kg/ jour EPA+DHA
Continuous
Maintains joint flexibility and improves mobility during exercise
Even without apparent joint symptoms, moderate omega-3 supplementation can help maintain joint flexibility, support the immune system and preserve skin and coat quality.
In healthy adult dogs, a daily intake of 14 mg of EPA+DHA per kilogram of body weight is recommended.
National Research Council
To make daily dosing easier, here is a reference guide by dog size:
Choosing a dosage tailored to your dog's weight
Tranche de poids
Poids moyen
Dosage quotidien recommandé (EPA+DHA)
Moins de 10 kg
7 kg
98 mg/jour
10 à 20 kg
15 kg
210 mg/jour
20 à 30 kg
30 kg
420 mg/jour
Plus de 40 kg
45 kg
630 mg/jour
These intakes can be provided by enriched food or by a supplement containing a high-quality omega-3 source such as green-lipped mussel oil or algae), well tolerated over the long term. They help maintain the mechanisms that regulate inflammation and support healthy ageing.
Choosing the Right Omega-3 Supplement for Your Dog
The choice of a supplement should not be based solely on price, but also on quality, stability and bioavailability (the body's ability to absorb ingested nutrients).
Concentration and Clinical Efficacy
An omega-3 supplement is only effective if the active forms, EPA and DHA, are present in sufficient quantities and in forms with demonstrated benefits.
Check the active ingredients: Only marine omega-3s, EPA and DHA, have a clinically demonstrated effect on inflammation and mobility (Barbeau-Grégoire et al., 2022). Plant-based omega-3s, in the form of ALA, are converted inefficiently in dogs.
Watch the concentration: Avoid products that feature well-known ingredients in nominal amounts. Effectiveness depends on reaching doses supported by scientific evidence.
Prefer the liquid form: Liquid oil is particularly suitable for omega-3s, offering good absorption and digestive tolerance compared with powders or chews, which are often underdosed.
The quality of an omega-3 oil is determined by its freshness and purity, which support its long-term effectiveness.
Stability and Oxidation: The oil must be non-oxidised. Oxidation,measured by the TOTOX index, makes the oil rancid and ineffective. A TOTOX index below 26 is an important indicator of quality. It helps confirm that the oil is fresh and pure, meaning it has not become rancid through contact with air.
Contaminant Testing: A reputable laboratory should provide release analyses confirming that environmental pollutants such as heavy metals, dioxins and PCBs are absent or remain within safe limits. This is particularly important for marine sources susceptible to bioaccumulation.
Traceability and Extraction: Look for full transparency regarding the origin of raw materials, including the fishing, farming or cultivation area and method, as well as the extraction process used. Gentle, solvent-free methods are preferable.
Choosing PERNIXOL® means choosing a formula developed to avoid the compromises associated with underdosed or clinically unproven supplements. Based on scientific evidence, it combines effectiveness, quality and natural ingredients.
PERNIXOL® is more than a supplement; it reflects a commitment to your dog's long-term well-being.
Its formula combines premium, highly concentrated, stable and traceable marine active ingredients:
New Zealand Green-Lipped Mussel Oil (Perna canaliculus): Farmed in the protected waters of the Marlborough Sounds, it provides the essential fatty acids EPA and DHA, as well as the rare omega-3 ETA, which contributes to its anti-inflammatory activity. It is the flagship ingredient for supporting canine mobility.
High-Purity Microalgae Oil (Schizochytrium sp.): Grown through fermentation to minimise the risk of contaminants, it provides a highly concentrated source of DHA and helps protect your dog's cartilage.
Manufactured in our laboratory in St-Jean-d'Illac, France (Gironde), PERNIXOL®is the only liquid formula rich in sustainable Omega-3for your dog's joint health.
Easy to dose and with a taste dogs love, PERNIXOL®gives your dog back the freedom to run, play and share every moment by your side without restraint.
Omega-3 are essential to the lasting health of your dog. This guide has demonstrated that not all Omega-3 are equal: only EPA and DHA, derived from pure and traceable marine sources, have the power to modulate inflammation and protect joints and the brain. Efficacy does not depend on chance, but on adherence to precise dosing and impeccable quality (low TOTOX, optimal concentration).
Key Takeaways
EPA and DHA are the most effective Omega-3 for dogs.
They support joints, skin and the brain.
Marine sources are more effective than plant-based sources.
Quality depends on purity, dosage and stability.
Regular supplementation helps preserve mobility and vitality.
By choosing a supplement such as PERNIXOL®, you are opting for science in the service of well-being, guaranteeing your companion the optimal intake to regain suppleness and vitality.
Bauer JE. The essential nature of dietary omega-3 fatty acids in dogs. J Am Vet Med Assoc. 2016 Dec 1;249(11):1267-1272. doi: 10.2460/javma.249.11.1267. PMID: 27875089.
Bauer JE. Therapeutic use of fish oils in companion animals. J Am Vet Med Assoc. 2011 Dec 1;239(11):1441-51. doi: 10.2460/javma.239.11.1441. PMID: 22087720.
Bauer JE. Responses of dogs to dietary omega-3 fatty acids. J Am Vet Med Assoc. 2007 Dec 1;231(11):1657-61. doi: 10.2460/javma.231.11.1657. PMID: 18052798.
National Research Council (NRC). (2006). Nutrient Requirements of Dogs and Cats. The National Academies Press.
Wander RC, Hall JA, Gradin JL, Du SH, Jewell DE. The ratio of dietary (n-6) to (n-3) fatty acids influences immune system function, eicosanoid metabolism, lipid peroxidation and vitamin E status in aged dogs. J Nutr. 1997 Jun;127(6):1198-205. doi: 10.1093/jn/127.6.1198. PMID: 9187636.
McPhee S, Hodges LD, Wright PF, Wynne PM, Kalafatis N, Harney DW, Macrides TA. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol. 2007 Mar;146(3):346-56. doi: 10.1016/j.cbpb.2006.11.001. Epub 2006 Nov 17. PMID: 17197217.
Treschow AP, Hodges LD, Wright PF, Wynne PM, Kalafatis N, Macrides TA. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol. 2007 Aug;147(4):645-56. doi: 10.1016/j.cbpb.2007.04.004. Epub 2007 Apr 14. PMID: 17543561.
Mehler SJ, May LR, King C, Harris WS, Shah Z. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016 Jun;109:1-7. doi: 10.1016/j.plefa.2016.03.015. Epub 2016 Mar 30. PMID: 27269707.
Adler N, Schoeniger A, Fuhrmann H. Polyunsaturated fatty acids influence inflammatory markers in a cellular model for canine osteoarthritis. J Anim Physiol Anim Nutr (Berl). 2018 Apr;102(2):e623-e632. doi: 10.1111/jpn.12804. Epub 2017 Oct 13. PMID: 29030883.
Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015 Apr;1851(4):469-84. doi: 10.1016/j.bbalip.2014.08.010. Epub 2014 Aug 20. PMID: 25149823.
Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. 2008 Jan;214(1):201-9. doi: 10.1002/jcp.21188. PMID: 17929247.
Ma J, Kitaura H, Ogawa S, Ohori F, Noguchi T, Marahleh A, Nara Y, Pramusita A, Kinjo R, Kanou K, Kishikawa A, Ichimura A, Mizoguchi I. Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120. Front Immunol. 2023 Jan 18;13:929690. doi: 10.3389/fimmu.2022.929690. PMID: 36741381; PMCID: PMC9889988.
Wang Z, Guo A, Ma L, Yu H, Zhang L, Meng H, Cui Y, Yu F, Yang B. Docosahexenoic acid treatment ameliorates cartilage degeneration via a p38 MAPK-dependent mechanism. Int J Mol Med. 2016 Jun;37(6):1542-50. doi: 10.3892/ijmm.2016.2567. Epub 2016 Apr 14. PMID: 27082436; PMCID: PMC4866951.
Roush JK, Cross AR, Renberg WC, Dodd CE, Sixby KA, Fritsch DA, Allen TA, Jewell DE, Richardson DC, Leventhal PS, Hahn KA. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J Am Vet Med Assoc. 2010 Jan 1;236(1):67-73. doi: 10.2460/javma.236.1.67. PMID: 20043801.
Moreau M, Troncy E, Del Castillo JR, Bédard C, Gauvin D, Lussier B. Effects of feeding a high omega-3 fatty acids diet in dogs with naturally occurring osteoarthritis. J Anim Physiol Anim Nutr (Berl). 2013 Oct;97(5):830-7. doi: 10.1111/j.1439-0396.2012.01325.x. Epub 2012 Jul 14. PMID: 22805303.
Fritsch D, Allen TA, Dodd CE, Jewell DE, Sixby KA, Leventhal PS, Hahn KA. Dose-titration effects of fish oil in osteoarthritic dogs. J Vet Intern Med. 2010 Sep-Oct;24(5):1020-6. doi: 10.1111/j.1939-1676.2010.0572.x. Epub 2010 Aug 12. Erratum in: J Vet Intern Med. 2011 Jan-Feb;25(1):167. PMID: 20707845.
Hansen RA, Harris MA, Pluhar GE, Motta T, Brevard S, Ogilvie GK, Fettman MJ, Allen KG. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J Nutr Biochem. 2008 Feb;19(2):101-8. doi: 10.1016/j.jnutbio.2007.01.008. Epub 2007 May 24. PMID: 17531456.
Magalhães TR, Lourenço AL, Gregório H, Queiroga FL. Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review. In Vivo. 2021 May-Jun;35(3):1419-1436. doi: 10.21873/invivo.12394. Epub 2021 Apr 28. PMID: 33910819; PMCID: PMC8193331.
Rodrigues RBA, Zafalon RVA, Rentas MF, Risolia LW, Macedo HT, Perini MP, Silva AMGD, Marchi PH, Balieiro JCC, Mendes WS, Vendramini THA, Brunetto MA. The Supplementation of Docosahexaenoic Acid-Concentrated Fish Oil Enhances Cognitive Function in Puppies. Animals (Basel). 2023 Sep 16;13(18):2938. doi: 10.3390/ani13182938. PMID: 37760338; PMCID: PMC10525578.
Smith CE, Freeman LM, Rush JE, Cunningham SM, Biourge V. Omega-3 fatty acids in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J Vet Intern Med. 2007 Mar-Apr;21(2):265-73. doi: 10.1892/0891-6640(2007)21[265:ofaibd]2.0.co;2. PMID: 17427387.
Nasciutti PR, Moraes AT, Santos TK, Gonçalves Queiroz KK, Costa APA, Amaral AR, Fernando Gomes Olivindo R, Pontieri CFF, Jeremias JT, Vendramini THA, Brunetto MA, Carvalho ROA. Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. PLoS One. 2021 Jul 15;16(7):e0254887. doi: 10.1371/journal.pone.0254887. PMID: 34265016; PMCID: PMC8282066.
Lloret, Josep & Vila Belmonte, Mar & Izquierdo, Angel & San, Joan & Porsmoguer, Sebastián. (2025). The unsustainability of the Omega-3 supply from seafood in the Mediterranean under global change. Food Policy. 136. 1-12. 10.1016/j.foodpol.2025.102972.
Sprague M, Dick JR, Tocher DR. Impact of sustainable feeds on omega-3 long-chain fatty acid levels in farmed Atlantic salmon, 2006-2015. Sci Rep. 2016 Feb 22;6:21892. doi: 10.1038/srep21892. PMID: 26899924; PMCID: PMC4761991.
Meyer, B. , Arata, J. A. , Atkinson, A. , Bahlburg, D. , Bernard, K. , Cárdenas, C. A. , Grant, S. M. , Hill, S. L. , Hüppe, L. , Ichii, T. , Kawaguchi, S. , Krafft, B. A. , Labrousse, S. , Maschette, D. , Piñones, A. , Reiss, C. , Siebenhüner, B. , Sylvester, Z. and Ziegler, P. (2025), Adjusting the management of the Antarctic krill fishery to meet the challenges of the 21st century, Proceedings of the National Academy of Sciences of the United States of America, 122 (37), e2412624122-e2412624122 . doi: 10.1073/pnas.2412624122
Zhang, Haiyan & Ji, Yunyun & Jiang, Zhongquan & Yang, Guangxin & Kong, Cong & Shen, Zhemin & Yuan, Tao & Shen, Xiaosheng. (2025). Arsenic toxicity in Antarctic krill oil and its impact on human intestinal cells. Ecotoxicology and Environmental Safety. 289. 117680. 10.1016/j.ecoenv.2025.117680.
Burri L, Hoem N, Banni S, Berge K. Marine omega-3 phospholipids: metabolism and biological activities. Int J Mol Sci. 2012 Nov 21;13(11):15401-19. doi: 10.3390/ijms131115401. PMID: 23203133; PMCID: PMC3509649.
Pollard B, Guilford WG, Ankenbauer-Perkins KL, Hedderley D. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. N Z Vet J. 2006 Jun;54(3):114-8. doi: 10.1080/00480169.2006.36622. PMID: 16751841.
Vijarnsorn M, Kwananocha I, Kashemsant N, Jarudecha T, Lekcharoensuk C, Beale B, Peirone B, Lascelles BDX. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis. BMC Vet Res. 2019 Oct 17;15(1):349. doi: 10.1186/s12917-019-2110-7. Erratum in: BMC Vet Res. 2020 Dec 16;16(1):486. doi: 10.1186/s12917-020-02713-9. PMID: 31623621; PMCID: PMC6798752.
Kang K, Kim N, Lim S, Kang B. Therapeutic Effect of Green-Lipped Mussel Oil on Pain and Functional Disability in Dogs with Clinical Osteoarthritis. J Vet Clin 2024;41:350-358. https://doi.org/10.17555/jvc.2024.41.6.350
Barbeau-Grégoire M, Otis C, Cournoyer A, Moreau M, Lussier B, Troncy E. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. Int J Mol Sci. 2022 Sep 8;23(18):10384. doi: 10.3390/ijms231810384. PMID: 36142319; PMCID: PMC9499673.
This guide was written by the R&D team at Laboratoire Sensilia, experts in animal nutrition.
Sensilia Laboratory is a French, family-owned and independent laboratory based in Gironde, France. Since 2019, we have been researching and manufacturing healthy, innovative wellness products.